Rediff.com » Business
Cipla to acquire two US-based pharma cos for $550 million
By Zeba Siddiqui
September 04, 2015 10:23 IST
Cipla Ltd, India's fourth-largest drugmaker by sales, said on Friday it has agreed to buy two generics businesses in the United States in an all-cash deal worth $550 million to get access to a wide range of products.
The companies to be acquired, InvaGen Pharmaceuticals Inc and Exelan Pharmaceuticals Inc, had combined sales of $225 million in the last twelve months to June 2015, Cipla said in a statement.
Source:
REUTERS© Copyright 2024 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
Recommended by Rediff.com
Big Pharma still betting on 'messed up' Indian drugs market
India should take US pharma complaints seriously
It's still a man's world, women sidelined in India Inc
12 most OUTRAGEOUS selfies ever taken
Sensex, Nifty rise on positive Wall Street cues; bluechips rule